{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:47:33Z","timestamp":1790876853120,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Familial Mediterranean fever (FMF) is the most common autoinflammatory disease of childhood and is frequently associated with systemic inflammatory diseases such as vasculitis. The aim of this study is to evaluate the impact of FMF on clinical and laboratory findings and disease activity of immunoglobulin A vasculitis (IgAV) at presentation.\u00a0Patients with IgAV who were followed up for more than 3 months were included in the study. Patients were divided into two subgroups regarding presence of FMF. Demographic characteristics, clinical findings in the first 3 months, laboratory findings at the time of diagnosis, vasculitis activity scores (PVAS), and treatments administered were recorded.\u00a0A total of 662 patients with IgAV were included in the study. FMF was diagnosed in 49 (7.4%) patients with IgAV. Patients with FMF had more gastrointestinal tract and renal involvement, higher PVAS score, higher C-reactive protein levels, and higher need for steroids, cyclophosphamide, and intravenous immunoglobulin (p\u2009=\u20090.01, p\u2009=\u20090.03, p\u2009&lt;\u20090.001, p\u2009&lt;\u20090.001, p\u2009=\u20090.04, p\u2009&lt;\u20090.001, p\u2009=\u20090.01, respectively). When patients were analyzed according to MEFV mutations, the effect of FMF on vasculitis was more prominent especially in patients carrying homozygous and compound heterozygous mutations in exon 10.<\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusion<\/jats:italic>:\u00a0FMF may lead to more severe clinical and laboratory findings and disease activity at the time of IgAV\u00a0diagnosis. The clinician should be aware that the course of IgAV may be affected by the presence of\u00a0FMF.<\/jats:p>\n          <jats:p>\n            <jats:italic>Trial registration<\/jats:italic>: E2-24\u20136125, 21.01.2024, retrospectively registered.\n<jats:table-wrap>\n              <jats:table>\n                <jats:tbody>\n                  <jats:tr>\n                    <jats:td colspan=\"2\">\n                      <jats:bold>What is Known:<\/jats:bold>\u2022 <jats:italic>In patients with familial Mediterranean fever (FMF), some vasculitides are more common and may affect the course of vasculitis.<\/jats:italic>\n                      <jats:bold>What is New:<\/jats:bold>\u2022 <jats:italic>At the time of immunoglobulin A vasculitis diagnosis, patients with FMF may have more system involvement, higher vasculitis activation scores, and acute phase reactants and require more intensive treatment than those without FMF.<\/jats:italic>\n                    <\/jats:td>\n                  <\/jats:tr>\n                <\/jats:tbody>\n              <\/jats:table>\n            <\/jats:table-wrap>\n          <\/jats:p>","DOI":"10.1007\/s00431-025-06091-y","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:02:52Z","timestamp":1744128172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["How familial Mediterranean fever affects the characteristics of immunoglobulin a vasculitis in pediatric patients at the time of diagnosis?"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7942-3714","authenticated-orcid":false,"given":"Mehve\u015f I\u015f\u0131klar","family":"Ekici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0129-4410","authenticated-orcid":false,"given":"Elif","family":"\u00c7elikel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-667X","authenticated-orcid":false,"given":"Zahide Ekici","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9838-2603","authenticated-orcid":false,"given":"Vildan","family":"G\u00fcng\u00f6rer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-1980","authenticated-orcid":false,"given":"C\u00fcneyt","family":"Karag\u00f6l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-2774","authenticated-orcid":false,"given":"Melike Mehve\u015f","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0403-151X","authenticated-orcid":false,"given":"Nimet","family":"\u00d6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-8435","authenticated-orcid":false,"given":"Merve Cansu","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-9225","authenticated-orcid":false,"given":"Didem","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4619-8342","authenticated-orcid":false,"given":"Emine","family":"\u00d6z\u00e7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3691-8708","authenticated-orcid":false,"given":"Yasemin U\u011fur","family":"Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8287-5972","authenticated-orcid":false,"given":"Sultan Nilay","family":"Yo\u011fun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-3655","authenticated-orcid":false,"given":"Banu \u00c7elikel","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"2 Suppl 53","key":"6091_CR1","first-page":"S29","volume":"27","author":"S Ozen","year":"2009","unstructured":"Ozen S (2009) Mutations\/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 27(2 Suppl 53):S29-31","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"6091_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/rheumatology\/kex373","volume":"57","author":"Y Jamilloux","year":"2018","unstructured":"Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, Penel-Page M, Hentgen V, S\u00e8ve P, Gerfaud-Valentin M et al (2018) Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the pyrin inflammasome. Rheumatology (Oxford) 57(1):100\u2013111. https:\/\/doi.org\/10.1093\/rheumatology\/kex373","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"6091_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00296-011-1840-z","volume":"31","author":"K Aksu","year":"2011","unstructured":"Aksu K, Keser G (2011) Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 31(10):1263\u20131274. https:\/\/doi.org\/10.1007\/s00296-011-1840-z","journal-title":"Rheumatol Int"},{"issue":"2","key":"6091_CR4","first-page":"323","volume":"24","author":"H Ozdogan","year":"1997","unstructured":"Ozdogan H, Arisoy N, Kasap\u00e7apur O, Sever L, Cali\u015fkan S, Tuzuner N, Mat C, Yazici H (1997) Vasculitis in familial Mediterranean fever. J Rheumatol 24(2):323\u2013327","journal-title":"J Rheumatol"},{"issue":"7","key":"6091_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10067-019-04489-2","volume":"38","author":"EK Cakici","year":"2019","unstructured":"Cakici EK, Kurt \u015e\u00fck\u00fcr ED, \u00d6zl\u00fc SG, Yaz\u0131l\u0131ta\u015f F, \u00d6zdel S, G\u00fcr G, Ero\u011flu FK, G\u00fcng\u00f6r T, \u00c7elikkaya E, Ba\u011flan E et al (2019) MEFV gene mutations in children with Henoch-Sch\u00f6nlein purpura and their correlations-do mutations matter? Clin Rheumatol 38(7):1947\u20131952. https:\/\/doi.org\/10.1007\/s10067-019-04489-2","journal-title":"Clin Rheumatol"},{"key":"6091_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1546-0096-12-41","volume":"12","author":"S Salah","year":"2014","unstructured":"Salah S, Rizk S, Lotfy HM, El Houchi S, Marzouk H, Farag Y (2014) MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura. Pediatr Rheumatol Online J 12:41. https:\/\/doi.org\/10.1186\/1546-0096-12-41","journal-title":"Pediatr Rheumatol Online J"},{"key":"6091_CR7","doi-asserted-by":"publisher","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, et al.; Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69(5):798\u2013806. https:\/\/doi.org\/10.1136\/ard.2009.116657.","DOI":"10.1136\/ard.2009.116657"},{"issue":"8","key":"6091_CR8","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E et al (2019) Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) Classification criteria for autoinflammatory recurrent fevers. Annals of the rheumatic diseases 78(8):1025\u20131032. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215048","journal-title":"Annals of the rheumatic diseases"},{"key":"6091_CR9","first-page":"456","volume-title":"Textbook of pediatric rheumatology","author":"P Broggan","year":"2021","unstructured":"Broggan P, Nott KA (2021) Immune complex small-vessel vasculitis:IgA vasculitis (Henoch\u2013Schonlein) and hypersensitivity. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR (eds) Textbook of pediatric rheumatology, 8th edn. Elsevier Saunders, Philadelphia, pp 456\u2013466","edition":"8"},{"issue":"10","key":"6091_CR10","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","volume":"72","author":"P Dolezalova","year":"2013","unstructured":"Dolezalova P, Price-Kuehne FE, \u00d6zen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O\u2019Neil KM, Wallace CA et al (2013) Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis 72(10):1628\u20131633. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202111","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"6091_CR11","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1468-1331.2011.03356.x","volume":"18","author":"G Yahalom","year":"2011","unstructured":"Yahalom G, Kivity S, Lidar M, Vaknin-Dembinsky A, Karussis D, Flechter S (2011) Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world\u2019s largest FMF cohorts. Eur J Neurol 18(9):1146\u20131150. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03356.x","journal-title":"Eur J Neurol"},{"issue":"12","key":"6091_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","volume":"16","author":"MH Heineke","year":"2017","unstructured":"Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M (2017) New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura). Autoimmun Rev 16(12):1246\u20131253. https:\/\/doi.org\/10.1016\/j.autrev.2017.10.009","journal-title":"Autoimmun Rev"},{"issue":"8","key":"6091_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fimmu.2017.00253","volume":"23","author":"S \u00d6zen","year":"2017","unstructured":"\u00d6zen S, Batu ED, Demir S (2017) Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Front Immunol 23(8):253. https:\/\/doi.org\/10.3389\/fimmu.2017.00253","journal-title":"Front Immunol"},{"issue":"9","key":"6091_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/ndt\/gfx300","volume":"33","author":"Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E; HSPrognosis Group; Monteiro RC, Pillebout E; members of the HSPrognosis Group","year":"2018","unstructured":"Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E; HSPrognosis Group; Monteiro RC, Pillebout E; members of the HSPrognosis Group (2018) Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant 33(9):1579\u20131590. https:\/\/doi.org\/10.1093\/ndt\/gfx300","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"6091_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/pde.12222","volume":"30","author":"N Mahajan","year":"2013","unstructured":"Mahajan N, Kapoor D, Bisht D, Singh S, Minz RW, Dhawan V (2013) Levels of interleukin-18 and endothelin-1 in children with Henoch-Sch\u00f6nlein purpura: a study from northern India. Pediatr Dermatol 30(6):695\u2013699. https:\/\/doi.org\/10.1111\/pde.12222","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"6091_CR16","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1177\/147323001103900616","volume":"39","author":"YB Wang","year":"2011","unstructured":"Wang YB, Shan NN, Chen O, Gao Y, Zou X, Wei DE, Wang CX, Zhang Y (2011) Imbalance of interleukin-18 and interleukin-18 binding protein in children with Henoch-Sch\u00f6nlein purpura. J Int Med Res 39(6):2201\u20132208. https:\/\/doi.org\/10.1177\/147323001103900616","journal-title":"J Int Med Res"},{"key":"6091_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fmed.2020.00092","volume":"7","author":"S Chang","year":"2020","unstructured":"Chang S, Li XK (2020) The role of immune modulation in pathogenesis of IgA nephropathy. Front Med 7:92. https:\/\/doi.org\/10.3389\/fmed.2020.00092","journal-title":"Front Med"},{"issue":"2","key":"6091_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1620\/tjem.255.157","volume":"255","author":"T Sasajima","year":"2021","unstructured":"Sasajima T, Fujita Y, Ejiri Y, Suzuki T, Wada J, Yokose K, Yoshida S, Matsumoto H, Asano T, Sato S, Yashiro-Furuya M, Matsuoka N, Temmoku J, Yago T, Watanabe H, Migita K (2021) Immunoglobulin A vasculitis in a Japanese patient with complete familial Mediterranean fever carrying MEFV exon 10 mutation. Tohoku J Exp Med 255(2):157\u2013162. https:\/\/doi.org\/10.1620\/tjem.255.157","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"6091_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/1756-185X.12072","volume":"16","author":"U Altug","year":"2013","unstructured":"Altug U, Ensari C, Sayin DB, Ensari A (2013) MEFV gene mutations in Henoch-Sch\u00f6nlein purpura. Int J Rheum Dis 16(3):347\u2013351. https:\/\/doi.org\/10.1111\/1756-185X.12072","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"6091_CR20","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3899\/jrheum.080405","volume":"35","author":"ZB Oz\u00e7akar","year":"2008","unstructured":"Oz\u00e7akar ZB, Yal\u00e7inkaya F, Cakar N, Acar B, Kasap\u00e7opur O, Ug\u00fcten D (2008) MEFV mutations modify the clinical presentation of Henoch-Sch\u00f6nlein purpura. J Rheumatol 35(12):2427\u20132429. https:\/\/doi.org\/10.3899\/jrheum.080405","journal-title":"J Rheumatol"},{"issue":"5","key":"6091_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1067\/S0022-3476(03)00502-X","volume":"143","author":"R Gershoni-Baruch","year":"2003","unstructured":"Gershoni-Baruch R, Broza Y, Brik R (2003) Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Sch\u00f6nlein purpura. J Pediatr 143(5):658\u2013661. https:\/\/doi.org\/10.1067\/S0022-3476(03)00502-X","journal-title":"J Pediatr"},{"issue":"1","key":"6091_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/mr\/road007","volume":"34","author":"F Tuncer Kuru","year":"2023","unstructured":"Tuncer Kuru F, Gokcen N, Yazici A, Cefle A (2023) Disease severity and genotype-phenotype correlation in adult patients with familial Mediterranean fever. Mod Rheumatol 34(1):214\u2013219. https:\/\/doi.org\/10.1093\/mr\/road007","journal-title":"Mod Rheumatol"},{"issue":"10","key":"6091_CR23","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/1756-185X.12929","volume":"21","author":"R Topaloglu","year":"2018","unstructured":"Topaloglu R, Batu ED, Y\u0131ld\u0131z \u00c7, Korkmaz E, \u00d6zen S, Be\u015fba\u015f N, \u00d6zalt\u0131n F (2018) Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease. Int J Rheum Dis 21(10):1857\u20131862. https:\/\/doi.org\/10.1111\/1756-185X.12929","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"6091_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/RHU.0000000000001953","volume":"29","author":"H Kisaoglu","year":"2023","unstructured":"Kisaoglu H, Baba O, Kalyoncu M (2023) Genotype-phenotype associations of children with familial Mediterranean fever in a cohort consisting of M694V mutation and \u0131mplications for colchicine-resistant disease. J Clin Rheumatol 29(4):207\u2013213. https:\/\/doi.org\/10.1097\/RHU.0000000000001953","journal-title":"J Clin Rheumatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06091-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:03:13Z","timestamp":1746907393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06091-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6091"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06091-y","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}